Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Safe Supply Announces Signing of Definitive Agreement to Acquire Drug Lab 118 (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Opsens Inc
T.OPS
Healthcare
Medical Devices
OpSens Inc. is a medical device cardiology-focused company. The Company offers an advanced optical-based pressure guidewire that aims at improving the clinical outcome of patients with coronary artery disease. The Company’s segments include Medical and Industrial. The Medical segment focuses on physiological measurements, such as Fractional Flow Reserve (FFR) and Diastolic Pressure Ratio (dPR...
) in the coronary artery disease market and also supplies a range of miniature optical sensors to measure pressure and temperature to be used in a range of applications that can be integrated into other medical devices. The Industrial segment develops, manufactures and installs fiber optic sensing solutions for critical and demanding industrial applications. Its flagship product, the OptoWire, is a second-generation fiber optic pressure guidewire designed to provide the lowest drift in the industry and lesions access. It is approved for sale in the United States, European Union, Japan and Canada.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:OPS)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
(5664)
•••
retiredcf
X
View Profile
View Bullboard History
Post by
retiredcf
on Nov 29, 2022 9:43am
Only a Matter of Time
Before Savvywire is used throughout the world. Put this one away, relax and come back in a couple of years with a big smile on your face. All IMHO of course. GLTA The launch in New Zealand
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Nov 29, 2022 7:00am
New Press Release - OPSENS ANNOUNCES FIRST SAVVYWIRE(TM) PROCEDURE IN NEW ZEALAND
QUEBEC CITY, Nov. 29, 2022 /CNW Telbec/ - OpSens Inc. ("OpSens" or the "Company") (TSX: OPS) (OTCQX: OPSSF), a medical device cardiology-focused company delivering innovative solutions based on its proprietary optical technology, today announced that Dr. Sanjeevan Pasupati, Director of Structural...
read article.
(24)
•••
Nadia6519
X
View Profile
View Bullboard History
Post by
Nadia6519
on Nov 27, 2022 9:18am
This morning's La Presse _ Richard Dufour
Positive sentiment in spite of tweak in rating from Raymond James (my comment). Opsens fait toujours l’unanimit sur Bay Street, mais un analyste a ajust sa recommandation mardi aprs que l
...more
(5664)
•••
retiredcf
X
View Profile
View Bullboard History
Post by
retiredcf
on Nov 25, 2022 10:20am
Stifel
Bargain basement price this morning. GLTA 09:18 AM EST, 11/25/2022 (MT Newswires) -- Stifel GMP on Friday reiterated its buy rating on the shares of Opsens (OPS.TO) and its C$3.75 price target
...more
(590)
•••
ddogold
X
View Profile
View Bullboard History
Comment by
ddogold
on Nov 25, 2022 10:12am
RE:Hang on from. Raymond James see Opsens trimmed at $ 5,00
Still holding but a smaller position . Still believe a buyout is our best option to maximize our products . Glta
(54)
•••
GoldenArm
X
View Profile
View Bullboard History
Comment by
GoldenArm
on Nov 25, 2022 9:04am
RE:RE:Paradigm Capital...
Keep an eye out fr Board additions. These will be the people that smooth out stuff before takeover by a big company.
(28)
•••
Qccity1
X
View Profile
View Bullboard History
Comment by
Qccity1
on Nov 24, 2022 1:01pm
RE:Paradigm Capital...
Maybe sharing the link will be better... OpSens is a takeout target, says Paradigm Capital - Cantech Letter
(28)
•••
Qccity1
X
View Profile
View Bullboard History
Post by
Qccity1
on Nov 24, 2022 12:59pm
Paradigm Capital...
OpSens is a takeout target, says Paradigm Capital Paradigm Capital analyst Scott McAuley still likes the look of Canadian medical device maker OpSens Inc
...more
(24)
•••
Nadia6519
X
View Profile
View Bullboard History
Post by
Nadia6519
on Nov 23, 2022 11:26am
Excellent coverage
In my humble opinion, the European market potential is currently being somewhat ignored. Once that part of the world starts moving, we should see interesting things. GLTA
(5664)
•••
retiredcf
X
View Profile
View Bullboard History
Post by
retiredcf
on Nov 23, 2022 10:00am
RBC 2
Their upside scenario target also remains at $5.00. GLTA November 22, 2022 Opsens Inc. FQ4/22: Revenues slightly below estimates; Positive early feedback on
...more
(52)
•••
bossu
X
View Profile
View Bullboard History
Post by
bossu
on Nov 23, 2022 8:49am
Hang on from. Raymond James see Opsens trimmed at $ 5,00
Investors have to be patient ! Despite continuing to have “strong conviction” on the potential for its SavvyWire product as it continues to gain traction on both sides of the border, Raymond
...more
(1812)
•••
Possibleidiot01
X
View Profile
View Bullboard History
Comment by
Possibleidiot01
on Nov 22, 2022 2:57pm
RE:RE:If I understand well...
Follow where the money went . Operating expenses for FY 2022 were $28.8 million compared with $19.6 million for FY 2021. The increase in operating expenses is primarily due to increased headcount
...more
(5664)
•••
retiredcf
X
View Profile
View Bullboard History
Comment by
retiredcf
on Nov 22, 2022 10:50am
RE:If I understand well...
Good to see a voice of reason. We may close the day in the green depending on how well the conference call goes. GLTA
(24)
•••
Nadia6519
X
View Profile
View Bullboard History
Post by
Nadia6519
on Nov 22, 2022 10:20am
If I understand well...
... The increased loss is primarily due to higher operating expenses to drive growth in coronary products and preparation of the large-scale launch of SavvyWire for TAVR (Transcatheter Aortic
...more
(5664)
•••
retiredcf
X
View Profile
View Bullboard History
Comment by
retiredcf
on Nov 22, 2022 9:55am
RE:RE:Q4 2022 revenues lower than Q3 2022
When people like this show up (with a total of 4 posts on SH), you know it's time to buy. GLTA
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Have you held units of a TD mutual fund (other than through a discount broker)? Learn more.
The Many Indications that the Gold and Silver Sector is on the Verge of a Multi-Year Super Cycle
New electric industrial heat technology to reduce greenhouse gas emissions
Discover Options Trading Strategies to Minimize your Tax Burden